488 related articles for article (PubMed ID: 17379635)
1. Sleep/wake fragmentation disrupts metabolism in a mouse model of narcolepsy.
Zhang S; Zeitzer JM; Sakurai T; Nishino S; Mignot E
J Physiol; 2007 Jun; 581(Pt 2):649-63. PubMed ID: 17379635
[TBL] [Abstract][Full Text] [Related]
2. Increase of histaminergic tuberomammillary neurons in narcolepsy.
Valko PO; Gavrilov YV; Yamamoto M; Reddy H; Haybaeck J; Mignot E; Baumann CR; Scammell TE
Ann Neurol; 2013 Dec; 74(6):794-804. PubMed ID: 24006291
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive detection of sleep/wake changes and cataplexy-like behaviors in orexin/ataxin-3 transgenic narcoleptic mice across the disease onset.
Sato M; Sagawa Y; Hirai N; Sato S; Okuro M; Kumar S; Kanbayashi T; Shimizu T; Sakai N; Nishino S
Exp Neurol; 2014 Nov; 261():744-51. PubMed ID: 25118620
[TBL] [Abstract][Full Text] [Related]
4. Effects of ambient temperature on sleep and cardiovascular regulation in mice: the role of hypocretin/orexin neurons.
Lo Martire V; Silvani A; Bastianini S; Berteotti C; Zoccoli G
PLoS One; 2012; 7(10):e47032. PubMed ID: 23056568
[TBL] [Abstract][Full Text] [Related]
5. Orexin gene therapy restores the timing and maintenance of wakefulness in narcoleptic mice.
Kantor S; Mochizuki T; Lops SN; Ko B; Clain E; Clark E; Yamamoto M; Scammell TE
Sleep; 2013 Aug; 36(8):1129-38. PubMed ID: 23904672
[TBL] [Abstract][Full Text] [Related]
6. Specificity of direct transition from wake to REM sleep in orexin/ataxin-3 transgenic narcoleptic mice.
Fujiki N; Cheng T; Yoshino F; Nishino S
Exp Neurol; 2009 May; 217(1):46-54. PubMed ID: 19416673
[TBL] [Abstract][Full Text] [Related]
7. Orexins: from neuropeptides to energy homeostasis and sleep/wake regulation.
Beuckmann CT; Yanagisawa M
J Mol Med (Berl); 2002 Jun; 80(6):329-42. PubMed ID: 12072908
[TBL] [Abstract][Full Text] [Related]
8. Reduced food anticipatory activity in genetically orexin (hypocretin) neuron-ablated mice.
Akiyama M; Yuasa T; Hayasaka N; Horikawa K; Sakurai T; Shibata S
Eur J Neurosci; 2004 Dec; 20(11):3054-62. PubMed ID: 15579160
[TBL] [Abstract][Full Text] [Related]
9. Hypocretins (orexins): clinical impact of the discovery of a neurotransmitter.
Baumann CR; Bassetti CL
Sleep Med Rev; 2005 Aug; 9(4):253-68. PubMed ID: 15979356
[TBL] [Abstract][Full Text] [Related]
10. Expression of a poly-glutamine-ataxin-3 transgene in orexin neurons induces narcolepsy-cataplexy in the rat.
Beuckmann CT; Sinton CM; Williams SC; Richardson JA; Hammer RE; Sakurai T; Yanagisawa M
J Neurosci; 2004 May; 24(18):4469-77. PubMed ID: 15128861
[TBL] [Abstract][Full Text] [Related]
11. Wake-promoting effects of ONO-4127Na, a prostaglandin DP1 receptor antagonist, in hypocretin/orexin deficient narcoleptic mice.
Sagawa Y; Sato M; Sakai N; Chikahisa S; Chiba S; Maruyama T; Yamamoto J; Nishino S
Neuropharmacology; 2016 Nov; 110(Pt A):268-276. PubMed ID: 27474349
[TBL] [Abstract][Full Text] [Related]
12. Hypocretin deficiency in narcolepsy with cataplexy is associated with a normal body core temperature modulation.
Grimaldi D; Agati P; Pierangeli G; Franceschini C; Guaraldi P; Barletta G; Vandi S; Cevoli S; Plazzi G; Montagna P; Cortelli P
Chronobiol Int; 2010 Sep; 27(8):1596-608. PubMed ID: 20854137
[TBL] [Abstract][Full Text] [Related]
13. Conditional ablation of orexin/hypocretin neurons: a new mouse model for the study of narcolepsy and orexin system function.
Tabuchi S; Tsunematsu T; Black SW; Tominaga M; Maruyama M; Takagi K; Minokoshi Y; Sakurai T; Kilduff TS; Yamanaka A
J Neurosci; 2014 May; 34(19):6495-509. PubMed ID: 24806676
[TBL] [Abstract][Full Text] [Related]
14. Roles of orexin/hypocretin in regulation of sleep/wakefulness and energy homeostasis.
Sakurai T
Sleep Med Rev; 2005 Aug; 9(4):231-41. PubMed ID: 15961331
[TBL] [Abstract][Full Text] [Related]
15. Hypocretins (orexins) and sleep-wake disorders.
Baumann CR; Bassetti CL
Lancet Neurol; 2005 Oct; 4(10):673-82. PubMed ID: 16168936
[TBL] [Abstract][Full Text] [Related]
16. Difference in obesity phenotype between orexin-knockout mice and orexin neuron-deficient mice with same genetic background and environmental conditions.
Hara J; Yanagisawa M; Sakurai T
Neurosci Lett; 2005 Jun; 380(3):239-42. PubMed ID: 15862893
[TBL] [Abstract][Full Text] [Related]
17. Genetic ablation of hypocretin neurons alters behavioral state transitions in zebrafish.
Elbaz I; Yelin-Bekerman L; Nicenboim J; Vatine G; Appelbaum L
J Neurosci; 2012 Sep; 32(37):12961-72. PubMed ID: 22973020
[TBL] [Abstract][Full Text] [Related]
18. Effects of paraxanthine and caffeine on sleep, locomotor activity, and body temperature in orexin/ataxin-3 transgenic narcoleptic mice.
Okuro M; Fujiki N; Kotorii N; Ishimaru Y; Sokoloff P; Nishino S
Sleep; 2010 Jul; 33(7):930-42. PubMed ID: 20614853
[TBL] [Abstract][Full Text] [Related]
19. Chronic alterations in monoaminergic cells in the locus coeruleus in orexin neuron-ablated narcoleptic mice.
Tsujino N; Tsunematsu T; Uchigashima M; Konno K; Yamanaka A; Kobayashi K; Watanabe M; Koyama Y; Sakurai T
PLoS One; 2013; 8(7):e70012. PubMed ID: 23922890
[TBL] [Abstract][Full Text] [Related]
20. Sleep related changes in blood pressure in hypocretin-deficient narcoleptic mice.
Bastianini S; Silvani A; Berteotti C; Elghozi JL; Franzini C; Lenzi P; Lo Martire V; Zoccoli G
Sleep; 2011 Feb; 34(2):213-8. PubMed ID: 21286242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
